Disease-free and overall survival were comparable between paclitaxel- and cisplatin-based heated chemotherapy regimens in ...

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

The CDK2 inhibitor INCB123667 showed positive efficacy and safety signals in platinum-resistant/refractory ovarian cancer.

Maya Ortiz of North Reading is organizing “Trotting In Teal,” an awareness/fundraising event for ovarian cancer that will be ...

When Nikki Myers, 33, found a lump in her neck last fall, she visited an urgent care clinic. She learned she had ovarian ...

Delta passengers were stranded on a tiny island in the middle of the Atlantic for 29 hours after midair engine trouble ...

A groundbreaking new therapy for ovarian cancer is being trialled on a Brisbane woman, in an Australian-first, which aims to ...

New research reveals PD-L1 expression enhances survival in advanced ovarian cancer, linking it to homologous recombination ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...

Cancer can often be difficult to detect in the early stages, particularly if it is a more 'subtle' form of the disease. So ...

New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...

Researchers identify PPP2R1A gene mutations as a new marker linked to better immunotherapy response and survival in ovarian ...